Soo Yu is Director of AIkido Pharma Inc.. Currently has a direct ownership of 820,478 shares of AIKI, which is worth approximately $3.12 Million. The most recent transaction as insider was on Jun 21, 2023, when has been sold 529,715 shares (Common Stock) at a price of $2.58 per share, resulting in proceeds of $1,366,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 820K
0% 3M change
0% 12M change
Total Value Held $3.12 Million

Soo Yu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2023
BUY
Grant, award, or other acquisition
$1,366,664 $2.58 p/Share
529,715 Added 39.23%
820,478 Common Stock
Sep 13 2022
BUY
Open market or private purchase
$185,359 $6.32 p/Share
29,329 Added 26.29%
82,224 Common Stock
Sep 12 2022
BUY
Open market or private purchase
$284,185 $6.33 p/Share
44,895 Added 45.91%
52,895 Common Stock
Aug 26 2022
BUY
Grant, award, or other acquisition
$48,000 $6.0 p/Share
8,000 Added 50.0%
8,000 Common Stock
SY

Soo Yu

Director
New York, NY

Track Institutional and Insider Activities on AIKI

Follow AIkido Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIKI shares.

Notify only if

Insider Trading

Get notified when an A Ikido Pharma Inc. insider buys or sells AIKI shares.

Notify only if

News

Receive news related to AIkido Pharma Inc.

Track Activities on AIKI